Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

TAPIT-1: Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1

NCT01758744 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01758744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01758744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
TAPIT-1: Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
Lead sponsor
University of Colorado, Denver
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2012
Completion date
July 31, 2016
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

copd, pulmonary hypertension